VistaGen Therapeutics, Inc.
VTGN
$0.24
-$0.01-3.04%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -13.03M | -16.27M | -18.90M | -19.42M | -15.10M |
| Total Depreciation and Amortization | 197.00K | 190.00K | 189.00K | 185.00K | 169.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 862.00K | 757.00K | 953.00K | 950.00K | 794.00K |
| Change in Net Operating Assets | -2.74M | -873.00K | 126.00K | 4.52M | -4.71M |
| Cash from Operations | -14.71M | -16.20M | -17.63M | -13.76M | -18.85M |
| Capital Expenditure | -- | 0.00 | -26.00K | -60.00K | -65.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | -99.00K | 130.00K | -34.00K | -723.00K |
| Cash from Investing | 0.00 | -99.00K | 104.00K | -94.00K | -788.00K |
| Total Debt Issued | -- | 0.00 | 0.00 | 0.00 | 1.02M |
| Total Debt Repaid | -96.00K | -283.00K | -278.00K | -274.00K | -90.00K |
| Issuance of Common Stock | 1.01M | 0.00 | 2.39M | 27.93M | 558.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 909.00K | -283.00K | 2.11M | 27.65M | 1.49M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -13.80M | -16.58M | -15.42M | 13.80M | -18.15M |